1.Alternative Name:TACSTD2
2.Target:TROP2
3.1Source:Human TROP2 was expressed from HEK293 with human IgG1 FC at the C-terminal
4.Sequence:Gln31-Thr274
5.Protein structure:P09758hFC
6.Molecular Characterization:The protein has a calculated MW of 53kDa.The reducing (R) heterodimer protein migrates as 60-75 kDa due to glycosylation
7.Purity:SDS-PAGE>95%，SEC>95%
8.Reconstitution:sterile H2O
9.Endotoxin:<1EU/mg
10
Formulation:Lyophilized from 0.22 μm filtered solution in PBS, pH7.4.
11.SDS-PAGE

Determined by SDS-PAGE, the purity of the protein is greater than 95%.

12.SEC-HPLC

Determined by SEC-HPLC, the purity of the protein is greater than 95%.

13.ELISA

When Recombinant Human TROP2/ hFC Protein is immobilized at 2μg/mL (100 μL/well), the concentration of Anti-Human TROP2[sacituzumab] that produces 50% of the optimal binding response is approximately 40 ng/ml.

Note:For research use only .